Historical return extremes for AbbVie (ABBV) from 2013 to 2026
What if you bought at the best or worst time? Max profit, max drawdown, and total return since IPO.
| Scenario | Return | Start date | Start price | End date | End price | $1,000 becomes |
|---|---|---|---|---|---|---|
| Max profitMore info about Max profit | +1,109% | $19.90 | $240.69 | $12,094.97 | ||
| Max drawdownMore info about Max drawdown | -45.09% | $87.45 | $48.02 | $549.11 | ||
| Return since IPOMore info about Return since IPO | +998.55% | $20.73 | $227.73 | $10,985.53 |
- Max profitMore info about Max profit+1,109%$12,094.97
- Max drawdownMore info about Max drawdown-45.09%$549.11
- Return since IPOMore info about Return since IPO+998.55%$10,985.53
Each row shows the start and end dates and prices for the scenario, the period return, and the resulting outcome for a $1,000 investment in AbbVie (ABBV). Max profit is the best buy-and-sell pair across the entire price history; max drawdown is the worst peak-to-trough decline; the last row tracks return from IPO to today. Prices are split- and dividend-adjusted closing prices — actual outcomes would differ due to fees, taxes, and slippage.
Frequently asked questions
Data & methodology
AbbVie (ABBV) Key Financials
Charts, filings, and peer comparison for every metric
Income Statement
Balance Sheet
Cash Flow
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
Overview
Income Statement